FSNUY
Fresenius SE & Co. KGaA
Price Chart
Latest Quote
$11.27
+0.17 (+1.53%)
Current Price
| Previous Close | $11.10 |
| Open | $11.16 |
| Day High | $11.32 |
| Day Low | $11.16 |
| Volume | 5,480 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $0.30 / 2.70% |
| Shares Outstanding | 2.25B |
| Quarterly Dividend Yield | 2.70% |
| Quarterly Dividend | $0.30 |
| Total Debt | $13.65B |
| Cash Equivalents | $2.36B |
| Revenue | $26.36B |
| Net Income | $1.74B |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $25.39B |
| P/E Ratio | 14.45 |
| EPS (TTM) | $0.78 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $35.92B |
| Sales | $26.36B |
| Income | $1.74B |
| Book/sh | $10.06 |
| Cash/sh | $0.91 |
| Employees | 178K |
Financial Ratios
| Quick Ratio | 0.65 |
| Current Ratio | 1.26 |
| Debt/Eq | 58.17 |
| EPS Growth TTM | 90.00% |
Returns & Margins
| ROA | 3.33% |
| ROE | 7.79% |
| Gross Margin | 25.29% |
| Operating Margin | 10.22% |
| Profit Margin | 6.40% |
Ownership
| Institutional Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 3.86 |
| PEG | 0.71 |
| P/S | 1.10 |
| P/B | 1.12 |
Analyst Data
| Recommendation | none |
| Target Price | $15.91 |
Technical Indicators
| SMA20 | $10.91 |
| SMA50 | $11.50 |
| SMA200 | $13.30 |
| RSI | 66.32 |
| ATR | 0.2986 |
| Shares Float | 1.64B |
| Volatility | 0.83 |
| Rel Volume | 0.99 |
Performance History
| Week | +3.11% |
| Month | -0.15% |
| Quarter | -10.83% |
| 6 Months | -16.97% |
| YTD | -17.15% |
| Year | -6.29% |
| 3 Years | +73.26% |
| 5 Years | -8.34% |
| 10 Years | -24.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $11.27 | 203,800 |
| 2026-06-17 | $11.10 | 244,000 |
| 2026-06-16 | $11.24 | 107,300 |
| 2026-06-15 | $11.25 | 270,500 |
| 2026-06-12 | $10.92 | 108,800 |
| 2026-06-11 | $10.93 | 249,600 |
| 2026-06-10 | $10.93 | 69,000 |
| 2026-06-09 | $10.83 | 183,300 |
| 2026-06-08 | $10.70 | 310,600 |
| 2026-06-05 | $10.80 | 221,000 |
| 2026-06-04 | $10.71 | 275,000 |
| 2026-06-03 | $10.51 | 137,900 |
| 2026-06-02 | $10.66 | 164,900 |
| 2026-06-01 | $10.40 | 334,300 |
| 2026-05-29 | $10.64 | 156,100 |
| 2026-05-28 | $10.78 | 279,300 |
| 2026-05-27 | $10.81 | 215,800 |
| 2026-05-26 | $11.14 | 280,900 |
| 2026-05-22 | $11.06 | 162,300 |
| 2026-05-21 | $11.52 | 125,700 |
| 2026-05-20 | $11.51 | 72,300 |
| 2026-05-19 | $11.29 | 195,300 |
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der HÃļhe, Germany.
đ° Latest News
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
Zacks âĸ 2026-06-15T13:40:04Z
Fresenius (FMS) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-06-01T21:28:25Z
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Zacks âĸ 2026-05-29T13:40:03Z
How The Fresenius SE KGaA (XTRA:FRE) Investment Story Is Evolving With Mixed Analyst Targets
Simply Wall St. âĸ 2026-04-23T19:07:24Z
Quest Diagnostics Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-21T14:45:18Z
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
Insider Monkey âĸ 2026-03-13T18:31:43Z
Here's Why Fresenius (FMS) is a Strong Value Stock
Zacks âĸ 2026-03-05T14:40:04Z
Assessing Fresenius SE KGaA (XTRA:FRE) Valuation After Recent Earnings And Shareholder Returns
Simply Wall St. âĸ 2026-03-01T11:08:36Z
Pacira BioSciences, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-27T13:30:00Z
Pacira BioSciences Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-27T06:12:58Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $16,455,000,000 | $16,096,000,000 | $16,129,000,000 | $27,209,000,000 |
| Cost Of Revenue | $16,455,000,000 | $16,096,000,000 | $16,129,000,000 | $27,209,000,000 |
| Total Revenue | $21,833,000,000 | $21,067,000,000 | $21,532,000,000 | $37,520,000,000 |
| Operating Revenue | $21,833,000,000 | $21,067,000,000 | $21,532,000,000 | $37,520,000,000 |
| Expenses | ||||
| Interest Expense | $547,000,000 | $519,000,000 | $345,000,000 | $630,000,000 |
| Total Expenses | $20,051,000,000 | $19,884,000,000 | $19,720,000,000 | $33,362,000,000 |
| Net Non Operating Interest Income Expense | $-432,000,000 | $-398,000,000 | $-215,000,000 | $-506,000,000 |
| Interest Expense Non Operating | $547,000,000 | $519,000,000 | $345,000,000 | $630,000,000 |
| Operating Expense | $3,596,000,000 | $3,788,000,000 | $3,591,000,000 | $6,153,000,000 |
| Other Operating Expenses | $329,000,000 | $517,000,000 | $211,000,000 | $276,000,000 |
| Selling And Marketing Expense | $697,000,000 | $742,000,000 | $746,000,000 | $1,059,000,000 |
| General And Administrative Expense | $2,222,000,000 | $2,285,000,000 | $2,348,000,000 | $4,394,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,042,000,000 | $1,394,000,000 | $477,000,000 | $1,818,000,000 |
| Net Interest Income | $-432,000,000 | $-398,000,000 | $-215,000,000 | $-506,000,000 |
| Interest Income | $115,000,000 | $121,000,000 | $130,000,000 | $124,000,000 |
| Normalized Income | $1,042,000,000 | $1,394,000,000 | $477,000,000 | $1,818,000,000 |
| Net Income From Continuing And Discontinued Operation | $471,000,000 | $-594,000,000 | $1,372,000,000 | $1,818,000,000 |
| Total Operating Income As Reported | $1,782,000,000 | $1,183,000,000 | $1,812,000,000 | $4,158,000,000 |
| Net Income Common Stockholders | $471,000,000 | $-594,000,000 | $1,372,000,000 | $1,818,000,000 |
| Net Income | $471,000,000 | $-594,000,000 | $1,372,000,000 | $1,818,000,000 |
| Net Income Including Noncontrolling Interests | $296,000,000 | $-1,700,000,000 | $2,117,000,000 | $2,819,000,000 |
| Net Income Discontinuous Operations | $-571,000,000 | $-1,988,000,000 | $895,000,000 | - |
| Net Income Continuous Operations | $867,000,000 | $288,000,000 | $1,222,000,000 | $2,819,000,000 |
| Pretax Income | $1,388,000,000 | $773,000,000 | $1,597,000,000 | $3,652,000,000 |
| Interest Income Non Operating | $115,000,000 | $121,000,000 | $130,000,000 | $124,000,000 |
| Operating Income | $1,782,000,000 | $1,183,000,000 | $1,812,000,000 | $4,158,000,000 |
| Gross Profit | $5,378,000,000 | $4,971,000,000 | $5,403,000,000 | $10,311,000,000 |
| Average Dilution Earnings | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $0.21 | $-0.26 | $0.61 | $0.81 |
| Basic EPS | $0.21 | $-0.26 | $0.61 | $0.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,139,000,000 | $2,692,000,000 | $3,099,000,000 | $6,949,000,000 |
| Reconciled Depreciation | $1,204,000,000 | $1,400,000,000 | $1,157,000,000 | $2,667,000,000 |
| EBITDA (Bullshit earnings) | $3,139,000,000 | $2,692,000,000 | $3,099,000,000 | $6,949,000,000 |
| EBIT | $1,935,000,000 | $1,292,000,000 | $1,942,000,000 | $4,282,000,000 |
| Diluted Average Shares | $2,252,949,108 | $2,252,949,108 | $2,245,057,220 | $2,232,625,300 |
| Basic Average Shares | $2,252,949,108 | $2,252,949,108 | $2,245,057,220 | $2,232,247,512 |
| Diluted NI Availto Com Stockholders | $471,000,000 | $-594,000,000 | $1,372,000,000 | $1,818,000,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $175,000,000 | $1,106,000,000 | $-745,000,000 | $-1,001,000,000 |
| Tax Provision | $521,000,000 | $485,000,000 | $375,000,000 | $833,000,000 |
| Research And Development | $641,000,000 | $661,000,000 | $639,000,000 | $805,000,000 |
| Selling General And Administration | $2,919,000,000 | $3,027,000,000 | $3,094,000,000 | $5,453,000,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,035,000,000 | $1,379,000,000 | $-15,413,000,000 | $-13,776,000,000 |
| Total Assets | $43,550,000,000 | $45,284,000,000 | $76,400,000,000 | $71,962,000,000 |
| Total Non Current Assets | $32,104,000,000 | $32,764,000,000 | $58,121,000,000 | $54,501,000,000 |
| Other Non Current Assets | $273,000,000 | $298,000,000 | $2,621,000,000 | $509,000,000 |
| Non Current Prepaid Assets | $61,000,000 | $80,000,000 | $141,000,000 | $115,000,000 |
| Non Current Deferred Taxes Assets | $411,000,000 | $360,000,000 | $831,000,000 | $858,000,000 |
| Financial Assets | $15,000,000 | $9,000,000 | $18,000,000 | $2,000,000 |
| Investmentin Financial Assets | $54,000,000 | $21,000,000 | $1,292,000,000 | $1,410,000,000 |
| Goodwill And Other Intangible Assets | $17,507,000,000 | $17,620,000,000 | $35,828,000,000 | $32,774,000,000 |
| Other Intangible Assets | $2,422,000,000 | $2,531,000,000 | $4,338,000,000 | $3,831,000,000 |
| Current Assets | $11,446,000,000 | $12,520,000,000 | $18,279,000,000 | $17,461,000,000 |
| Other Current Assets | $613,000,000 | $672,000,000 | $3,536,000,000 | $564,000,000 |
| Hedging Assets Current | $12,000,000 | $33,000,000 | $40,000,000 | $18,000,000 |
| Assets Held For Sale Current | $310,000,000 | $555,000,000 | $0 | - |
| Restricted Cash | $236,000,000 | $273,000,000 | $180,000,000 | $154,000,000 |
| Prepaid Assets | $143,000,000 | $154,000,000 | $493,000,000 | $432,000,000 |
| Inventory | $2,573,000,000 | $2,517,000,000 | $4,833,000,000 | $4,218,000,000 |
| Other Receivables | $1,694,000,000 | $2,056,000,000 | $1,573,000,000 | $1,788,000,000 |
| Taxes Receivable | $319,000,000 | $298,000,000 | $568,000,000 | $496,000,000 |
| Accounts Receivable | $3,500,000,000 | $3,673,000,000 | $7,161,000,000 | $7,045,000,000 |
| Allowance For Doubtful Accounts Receivable | $-316,000,000 | $-348,000,000 | $-473,000,000 | $-449,000,000 |
| Gross Accounts Receivable | $3,816,000,000 | $4,021,000,000 | $7,634,000,000 | $7,494,000,000 |
| Cash Cash Equivalents And Short Term Investments | $2,046,000,000 | $2,289,000,000 | $2,569,000,000 | $2,746,000,000 |
| Cash And Cash Equivalents | $2,046,000,000 | $2,289,000,000 | $2,569,000,000 | $2,610,000,000 |
| Cash Equivalents | - | - | - | $931,000,000 |
| Cash Financial | - | - | - | $1,833,000,000 |
| Debt | ||||
| Net Debt | $10,031,000,000 | $11,543,000,000 | $18,602,000,000 | $17,955,000,000 |
| Total Debt | $13,577,000,000 | $15,830,000,000 | $27,763,000,000 | $27,155,000,000 |
| Long Term Debt And Capital Lease Obligation | $10,805,000,000 | $13,249,000,000 | $24,727,000,000 | $22,383,000,000 |
| Long Term Debt | $9,477,000,000 | $11,457,000,000 | $18,986,000,000 | $16,625,000,000 |
| Current Debt And Capital Lease Obligation | $2,772,000,000 | $2,581,000,000 | $3,036,000,000 | $4,772,000,000 |
| Current Debt | $2,600,000,000 | $2,375,000,000 | $2,185,000,000 | $3,940,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $23,260,000,000 | $25,633,000,000 | $44,182,000,000 | $42,674,000,000 |
| Total Non Current Liabilities Net Minority Interest | $14,251,000,000 | $16,303,000,000 | $30,524,000,000 | $27,612,000,000 |
| Other Non Current Liabilities | $123,000,000 | $229,000,000 | $298,000,000 | $250,000,000 |
| Derivative Product Liabilities | $676,000,000 | $508,000,000 | $1,314,000,000 | $359,000,000 |
| Tradeand Other Payables Non Current | $362,000,000 | $279,000,000 | $277,000,000 | $327,000,000 |
| Non Current Deferred Taxes Liabilities | $627,000,000 | $531,000,000 | $1,654,000,000 | $1,515,000,000 |
| Current Liabilities | $9,009,000,000 | $9,330,000,000 | $13,658,000,000 | $15,062,000,000 |
| Other Current Liabilities | $431,000,000 | $616,000,000 | $2,595,000,000 | $2,424,000,000 |
| Payables | $2,418,000,000 | $2,553,000,000 | $4,164,000,000 | $3,820,000,000 |
| Other Payable | $300,000,000 | $243,000,000 | $1,089,000,000 | $953,000,000 |
| Total Tax Payable | $340,000,000 | $325,000,000 | $514,000,000 | $558,000,000 |
| Accounts Payable | $1,778,000,000 | $1,985,000,000 | $2,561,000,000 | $2,309,000,000 |
| Equity | ||||
| Common Stock Equity | $19,542,000,000 | $18,999,000,000 | $20,415,000,000 | $18,998,000,000 |
| Total Equity Gross Minority Interest | $20,290,000,000 | $19,651,000,000 | $32,218,000,000 | $29,288,000,000 |
| Stockholders Equity | $19,542,000,000 | $18,999,000,000 | $20,415,000,000 | $18,998,000,000 |
| Long Term Equity Investment | $3,655,000,000 | $3,535,000,000 | - | - |
| Investments In Other Ventures Under Equity Method | $16,000,000 | $35,000,000 | - | - |
| Other | ||||
| Ordinary Shares Number | $563,237,277 | $563,237,277 | $563,237,277 | $559,526,994 |
| Share Issued | $563,237,277 | $563,237,277 | $563,237,277 | $559,526,994 |
| Tangible Book Value | $2,035,000,000 | $1,379,000,000 | $-15,413,000,000 | $-13,776,000,000 |
| Invested Capital | $31,619,000,000 | $32,831,000,000 | $41,586,000,000 | $39,563,000,000 |
| Working Capital | $2,437,000,000 | $3,190,000,000 | $4,621,000,000 | $2,399,000,000 |
| Capital Lease Obligations | $1,500,000,000 | $1,998,000,000 | $6,592,000,000 | $6,590,000,000 |
| Total Capitalization | $29,019,000,000 | $30,456,000,000 | $39,401,000,000 | $35,623,000,000 |
| Minority Interest | $748,000,000 | $652,000,000 | $11,803,000,000 | $10,290,000,000 |
| Additional Paid In Capital | $4,315,000,000 | $4,326,000,000 | $4,323,000,000 | $4,026,000,000 |
| Capital Stock | $563,000,000 | $563,000,000 | $563,000,000 | $558,000,000 |
| Common Stock | $563,000,000 | $563,000,000 | $563,000,000 | $558,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $621,000,000 | $666,000,000 | $1,312,000,000 | $1,901,000,000 |
| Non Current Accrued Expenses | $285,000,000 | $312,000,000 | $348,000,000 | $487,000,000 |
| Non Current Deferred Revenue | $31,000,000 | $40,000,000 | $23,000,000 | $30,000,000 |
| Long Term Capital Lease Obligation | $1,328,000,000 | $1,792,000,000 | $5,741,000,000 | $5,758,000,000 |
| Long Term Provisions | $717,000,000 | $523,000,000 | $571,000,000 | $360,000,000 |
| Current Capital Lease Obligation | $172,000,000 | $206,000,000 | $851,000,000 | $832,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,236,000,000 | $1,309,000,000 | $1,815,000,000 | $1,766,000,000 |
| Current Provisions | $508,000,000 | $640,000,000 | $823,000,000 | $861,000,000 |
| Available For Sale Securities | $54,000,000 | $21,000,000 | $1,017,000,000 | $1,124,000,000 |
| Investmentsin Associatesat Cost | $3,639,000,000 | $3,500,000,000 | - | - |
| Goodwill | $15,085,000,000 | $15,089,000,000 | $31,490,000,000 | $28,943,000,000 |
| Net PPE | $9,890,000,000 | $10,782,000,000 | $18,841,000,000 | $18,583,000,000 |
| Accumulated Depreciation | $-6,807,000,000 | $-6,798,000,000 | $-15,802,000,000 | $-13,688,000,000 |
| Gross PPE | $16,697,000,000 | $17,580,000,000 | $34,643,000,000 | $32,271,000,000 |
| Construction In Progress | $1,147,000,000 | $1,903,000,000 | $2,445,000,000 | $2,172,000,000 |
| Other Properties | $242,000,000 | $250,000,000 | $566,000,000 | $603,000,000 |
| Machinery Furniture Equipment | $6,335,000,000 | $5,889,000,000 | $11,703,000,000 | $11,019,000,000 |
| Buildings And Improvements | $8,130,000,000 | $8,638,000,000 | $18,903,000,000 | $17,444,000,000 |
| Land And Improvements | $843,000,000 | $900,000,000 | $1,026,000,000 | $1,033,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-173,000,000 | $-132,000,000 | $-143,000,000 | $-154,000,000 |
| Finished Goods | $1,589,000,000 | $1,472,000,000 | $3,309,000,000 | $2,961,000,000 |
| Work In Process | $274,000,000 | $279,000,000 | $467,000,000 | $440,000,000 |
| Raw Materials | $883,000,000 | $898,000,000 | $1,200,000,000 | $971,000,000 |
| Other Short Term Investments | - | $1,504,000,000 | $170,000,000 | $136,000,000 |
| Held To Maturity Securities | - | - | $275,000,000 | $286,000,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,524,000,000 | $3,403,000,000 | $3,005,000,000 | $2,032,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,447,000,000 | $4,456,000,000 | $4,198,000,000 | $5,078,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-923,000,000 | $-1,053,000,000 | $-1,193,000,000 | $-3,046,000,000 |
| Investing Cash Flow | $-510,000,000 | $-3,187,000,000 | $-2,607,000,000 | $-2,817,000,000 |
| Net Other Investing Changes | $-20,000,000 | $-732,000,000 | $-735,000,000 | - |
| Capital Expenditure Reported | - | - | - | $-2,017,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-2,183,000,000 | $-1,377,000,000 | $-1,604,000,000 | $-1,452,000,000 |
| Net Other Financing Charges | $-62,000,000 | $-1,526,000,000 | $-1,540,000,000 | $-24,000,000 |
| Common Stock Dividend Paid | $0 | $-551,000,000 | $-403,000,000 | $-1,068,000,000 |
| Dividends Received Cfi | $112,000,000 | $106,000,000 | - | - |
| Issuance Of Capital Stock | - | $0 | $0 | $38,000,000 |
| Cash Dividends Paid | - | $-551,000,000 | $-403,000,000 | $-1,068,000,000 |
| Net Common Stock Issuance | - | $0 | $0 | $38,000,000 |
| Common Stock Issuance | - | $0 | $0 | $38,000,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-2,242,000,000 | $-1,634,000,000 | $-2,394,000,000 | $-5,969,000,000 |
| Issuance Of Debt | $302,000,000 | $2,520,000,000 | $2,933,000,000 | $6,451,000,000 |
| End Cash Position | $2,282,000,000 | $2,562,000,000 | $2,749,000,000 | $2,764,000,000 |
| Other Cash Adjustment Outside Changein Cash | $-32,000,000 | $-36,000,000 | - | - |
| Beginning Cash Position | $2,562,000,000 | $2,749,000,000 | $2,764,000,000 | $1,837,000,000 |
| Effect Of Exchange Rate Changes | $-2,000,000 | $-43,000,000 | $-2,000,000 | $118,000,000 |
| Changes In Cash | $-246,000,000 | $-108,000,000 | $-13,000,000 | $809,000,000 |
| Net Issuance Payments Of Debt | $-1,940,000,000 | $886,000,000 | $539,000,000 | $482,000,000 |
| Net Short Term Debt Issuance | $-444,000,000 | $353,000,000 | $-1,372,000,000 | $2,591,000,000 |
| Short Term Debt Payments | $-496,000,000 | $-61,000,000 | $-1,594,000,000 | $-688,000,000 |
| Short Term Debt Issuance | $52,000,000 | $414,000,000 | $222,000,000 | $3,279,000,000 |
| Net Long Term Debt Issuance | $-1,496,000,000 | $533,000,000 | $1,911,000,000 | $-2,109,000,000 |
| Long Term Debt Payments | $-1,746,000,000 | $-1,573,000,000 | $-800,000,000 | $-5,281,000,000 |
| Long Term Debt Issuance | $250,000,000 | $2,106,000,000 | $2,711,000,000 | $3,172,000,000 |
| Net Investment Purchase And Sale | $314,000,000 | $-232,000,000 | $29,000,000 | $199,000,000 |
| Sale Of Investment | $394,000,000 | $1,000,000 | $29,000,000 | $199,000,000 |
| Purchase Of Investment | $-80,000,000 | $-233,000,000 | - | - |
| Net PPE Purchase And Sale | $-916,000,000 | $-1,026,000,000 | $-1,089,000,000 | $-2,017,000,000 |
| Sale Of PPE | $7,000,000 | $27,000,000 | $104,000,000 | $30,000,000 |
| Purchase Of PPE | $-923,000,000 | $-1,053,000,000 | $-1,193,000,000 | $-2,047,000,000 |
| Change In Working Capital | $336,000,000 | $399,000,000 | $-257,000,000 | $-534,000,000 |
| Change In Other Current Assets | $175,000,000 | $-153,000,000 | $-635,000,000 | $-330,000,000 |
| Change In Payable | $195,000,000 | $1,115,000,000 | $484,000,000 | $-186,000,000 |
| Change In Inventory | $-55,000,000 | $-176,000,000 | $-268,000,000 | $-105,000,000 |
| Change In Receivables | $21,000,000 | $-387,000,000 | $162,000,000 | $87,000,000 |
| Deferred Tax | $33,000,000 | $-2,000,000 | $-74,000,000 | $84,000,000 |
| Depreciation And Amortization | $1,204,000,000 | $1,400,000,000 | $1,157,000,000 | $2,667,000,000 |
| Depreciation | $1,204,000,000 | $1,400,000,000 | $1,157,000,000 | $2,667,000,000 |
| Gain Loss On Sale Of PPE | $-1,000,000 | $-20,000,000 | $-17,000,000 | $42,000,000 |
| Net Income From Continuing Operations | $867,000,000 | $288,000,000 | $1,222,000,000 | $2,819,000,000 |
| Net Business Purchase And Sale | - | $-1,303,000,000 | $-812,000,000 | $-999,000,000 |
| Purchase Of Business | - | $-1,303,000,000 | $-812,000,000 | $-999,000,000 |
| Net Intangibles Purchase And Sale | - | - | $-977,000,000 | $-999,000,000 |
| Purchase Of Intangibles | - | - | $-977,000,000 | $-999,000,000 |
| Common Stock Payments | - | - | - | $0 |
Fetched: 2026-02-02